Indikation: Diabetes - Typ II Clinical Trials

A listing of Indikation: Diabetes - Typ II medical research trials actively recruiting patient volunteers. Search for closest city to find more detailed information on a research study in your area.

Filter By
Clear all Advanced
I am/have/had
added new label for I am/have/had
more
I am looking for
added new label for I am looking for
more
Advanced Filters
Found 23 clinical trials
Featured trial
Do you have TYPE 2 DIABETES and have NEVER used insulin?

You can identify as potentially eligible for a clinical trial for the treatment of Type 2 Diabetes. The study compares the efficacy and safety of a weekly insulin compared to insulin glargine daily therapy. Medical care and study medications would be provided at no cost. Is this something you would …

insulin
hemoglobin a1c
  • 0 views
  • 03 Feb, 2023
  • 1 location
Featured trial
Are you taking BASAL INSULIN to treat your TYPE 2 Diabetes?

The COMBINE 1 study is a long-term study comparing efficacy and safety of two new injectable investigational medicines for the treatment of Type 2 Diabetes. This study is part of a global program of clinical studies investigating how well a new investigational combination product taken once-weekly (IcoSema) affects blood sugar …

semaglutide
insulin
sugars
  • 7 views
  • 08 Dec, 2022
  • 1 location
Featured trial
If you are living with OVERWEIGHT or OBESITY, then the REDEFINE 2 study may be for you

If you are living with overweight or obesity, then the REDEFINE 2 study may be for you. This study investigates the effect of an investigational medicine on weight loss.

overweight or obesity
diabetes
hemoglobin a1c
  • 55 views
  • 03 Feb, 2023
  • 1 location
Featured trial
Has Diabetes Affected Your Life?

Be part of a new approach to Diabetes care! AMCR Institute is currently recruiting for clinical trials to evaluate medical devices and investigational medications for pediatric and adult individuals with Type 1, Type 2 Diabetes, and obesity. AMCR Institute's team is committed to providing superior service to our volunteers and …

diabetes
  • 7 views
  • 29 Nov, 2022
  • 1 location
A Phase 2/3, Multicenter, Randomized, Double-blind, Placebo-Controlled, Adaptive Design Study to Evaluate the Efficacy and Safety of MK-5475 in Adults With Pulmonary Arterial Hypertension

This is a two-part (Phase 2/Phase 3) study of MK-5475, an inhaled soluble guanylate cyclase stimulator, in participants with pulmonary arterial hypertension (PAH). The first part (Phase 2) will assess three different doses of MK-5475 compared to placebo in a base period of 12 weeks, followed by comparison of three …

left ventricular end-diastolic pressure
pulmonary arterial hypertension
right heart catheterization
body mass index
heart disease
  • 38 views
  • 20 Oct, 2022
  • 76 locations
The Prophet Trial -Pilot Study to Assess Safety and Efficacy of a Novel Atrial Flow Regulator (AFR) in Patients With Pulmonary Hypertension (AFR-Prophet)

This study aims to investigate safety and efficacy of Occlutech® AFR device in patients with severe pulmonary hypertension (PH).

right ventricular failure
pulmonary arterial pressure
heart failure
  • 46 views
  • 07 Oct, 2022
  • 12 locations
A Randomized, Multicenter, Double-Blind, Placebo-Controlled, Parallel-Group, Event-Driven, Group-Sequential Study With Open-Label Extension Period to Assess the Efficacy and Safety of Selexipag as Add-On Treatment to Standard of Care in Children Aged >=2 to <18 Years With Pulmonary Arterial Hypertension (SALTO)

The purpose of this study is to evaluate whether the addition of selexipag to standard of care treatment delays disease progression in children with Pulmonary Arterial Hypertension (PAH) in comparison to placebo.

pulmonary arterial hypertension
primary pulmonary hypertension
right heart catheterization
endothelin
heart disease
  • 247 views
  • 25 Oct, 2022
  • 84 locations
A Study of Ralinepag to Evaluate Effects on Exercise Capacity by CPET in Subjects With WHO Group 1 PH (CAPACITY)

Study ROR-PH-302, ADVANCE CAPACITY, is designed to evaluate the effects of ralinepag therapy on exercise capacity as assessed by change in peak oxygen consumption (VO2) derived from cardiopulmonary exercise testing (CPET) after 28 weeks of treatment

ralinepag
exercise stress test
stress test
endothelin
cardiopulmonary exercise testing
  • 4 views
  • 04 Oct, 2022
  • 36 locations
An Open-label, Multi-national, Multi-center, Single-arm, Uncontrolled, Long-term Extension Study of Orally Administered Riociguat in Patients With Symptomatic Pulmonary Arterial Hypertension (PAH) Who Received Riociguat in a Bayer Clinical Trial (RIALTO)

To provide riociguat therapy to eligible patients with PAH originating from Bayer-sponsored trials with BAY63-2521/ Riociguat / Adempas® who are currently or recently treated in these trials until lack of patient benefit as assessed by investigator, or commercial availability and reimbursement.

pulmonary arterial hypertension
riociguat
adempas
  • 2 views
  • 24 Oct, 2022
  • 1 location
Training Single Arm

The pulmonary hypertension is a disease, which tends to a progredient right heart failure. Although there was a large progress in development of medical therapy, the quality of life, the physical efficiency and the prognosis of the patients are still limited. The aim of the study is to examine the …

heart failure
right heart catheterization
right ventricular failure
  • 1 views
  • 04 Oct, 2022
  • 1 location